1. Home
  2. BETR vs ELDN Comparison

BETR vs ELDN Comparison

Compare BETR & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Better Home & Finance Holding Company

BETR

Better Home & Finance Holding Company

N/A

Current Price

$15.27

Market Cap

204.6M

Sector

Finance

ML Signal

N/A

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

N/A

Current Price

$2.12

Market Cap

219.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BETR
ELDN
Founded
2014
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
204.6M
219.4M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
BETR
ELDN
Price
$15.27
$2.12
Analyst Decision
Buy
Strong Buy
Analyst Count
8
6
Target Price
★ $24.00
$9.00
AVG Volume (30 Days)
849.4K
★ 910.2K
Earning Date
11-09-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
20.88
★ 30.67
EPS
N/A
★ N/A
Revenue
★ $164,872,000.00
N/A
Revenue This Year
$13.39
N/A
Revenue Next Year
$23.31
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 51.97
N/A
52 Week Low
$7.51
$1.35
52 Week High
$55.75
$4.49

Technical Indicators

Market Signals
Indicator
BETR
ELDN
Relative Strength Index (RSI) 45.92 38.28
Support Level $10.45 N/A
Resistance Level $31.07 $3.19
Average True Range (ATR) 2.39 0.28
MACD -0.68 -0.03
Stochastic Oscillator 3.48 3.05

Price Performance

Historical Comparison
BETR
ELDN

About BETR Better Home & Finance Holding Company

Better Home & Finance Holding Co is a technology-enabled homeownership company that provides mortgage, home equity, and related services through a digital platform. The company operates through two reportable segments: Home Finance, which focuses on residential mortgage origination, including purchase, refinance, and home equity products, generating revenue mainly from loan sales; and Banking, which, through its U.K. subsidiary Birmingham Bank, offers a range of financial products and services to consumers and small businesses. It generates the majority of its revenue from the Home Finance segment.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

Share on Social Networks: